New Hampshire § 329-52 - Section 329:52 Definitions.

§ 329-52. Section 329:52 Definitions.

In this subdivision: I. "Abnormal development" means: (a) "Gynecomastia" which is the abnormal development of breast tissue in biological males; (b) "Macromastia" which is excessive development of breast tissue in biological females and includes juvenile hypertrophy of the breast and gigantomastia; or (c) "Symptomatic macromastia" is macromastia which causes pain, deformity and/or recurrent skin infection. II. "Breast surgery" includes: (a) "Mammaplasty" which means surgery to reshape or resize the breasts by removing or transplanting tissue or inserting implants; (b) "Mastectomy" which means surgery to remove all breast tissue; and/or (c) "Mastopexy" which means surgery to lift the breast. III. "Malignant" means cancerous or otherwise dangerous to the physical health of the person, including physiology compromised by infection, lack of blood flow, or physical injury. IV. "Margin" means the healthy tissue removed around malignant tissue to ensure that all malignancy has been removed, and any additional tissue as recommended by relevant medical guidelines. V. "Transgender chest surgery" means surgery to remove the breasts of a biological female through mastectomy or to increase the size of breasts of a biological male through augmentation mammaplasty, except in cases where such surgery is physiologically necessary, or is reconstructive in nature. In this paragraph, "physiologically necessary" refers to interventions, procedures, medications, or therapies essential for maintaining or restoring normal physiological function, preventing life-threatening conditions, or ensuring survival by addressing critical bodily needs, such as stabilizing vital systems, correcting severe imbalances, or supporting essential biological processes.